Skip to main content

The Top Ten International Drug Policy Stories of 2016 [FEATURE]

Submitted by Phillip Smith on (Issue #956)

(See our Top Ten Domestic Drug Policy Stories of 2016 feature story too.)

The year that just ended has seen a serious outbreak of bloody violence against drug users and sellers in one country, it has seen drug offenders hung by the hundreds in another, it has seen efforts to fight the spread of drug-related HIV/AIDS falter for lack of funding, and it has seen the tenacity of the prohibitionist apparatus in the halls of the United Nations.

But there was also good news emanating from various corners of the world, including advances in marijuana legalization in Canada, the US, and Europe and the flouting of the proscription against the coca trade in the UN anti-drug treaties. And speaking of treaties, alhough we didn't include it this year because the drug policy implications remain unclear, the fruition of years'-long peace negotiations between Colombia and the leftist rebels of the FARC, which brings an end to the Western hemisphere's longest-running guerrilla war, is certainly worth noting.

Here are the ten most notable international drug policy events of 2016, the good, the bad, and the ugly:

The UN General Assembly Special Session on Drugs saw progress, but achingly little. (Wikimedia.org)
1. The UN General Assembly Special Session (UNGASS) on Drugs

The global prohibitionist consenus was under growing strain at the UNGASS on Drugs, as civil society pressed the UN bureaucracy and member states for reforms as never before. But changes come at a glacial pace at the level of global diplomacy, and the vision of the UNGASS as a platform for discussing fundamental issues and plotting a new course ran up against the resistance of drug war hard-liners like Russia and China, and the studied indifference of European governments, who preferred that the UN drug policy center of gravity remain at the Commission on Narcotic Drugs in Vienna. And while the US delegation advocated for some good stances, it, too, opposed any meddling with the trio of UN conventions that form the legal backbone of global drug prohibition.

Still, there were some incremental victories. UN agencies submitted their own position papers, many highly progressive, as were the submissions from some countries and international organizations. EU states and others fought hard for language opposing the death penalty for drug offenses, though unsuccessfully. And while the UNGASS Outcome Document avoids most big issues, it puts strong emphasis on treatment and alternatives to incarceration. It acknowledges the importance of human rights and proportionate sentencing. It has support for naloxone (the overdose antidote), medication-assisted treatment (e.g. methadone and buprenorphine), and safe injecting equipment, though avoiding the term "harm reduction" itself. And it calls for addressing obstacles to opioid availability. (Read a detailed report on UNGASS by some of our colleagues here, and read about some of our own work for the UNGASS here.)

2. Global Harm Reduction for AIDS Remains Tragically Underfunded, and Facing Worse. Despite the repeatedly-proven positive impact of harm reduction measures in reducing the spread and prevalence of HIV/AIDS, donors continue to refuse to pony up to pay for such measures. The UNAIDS program estimates that $2.3 billion was needed to fund AIDS-related harm reduction programs last year, but only $160 million was actually invested by donors as most member states cut their aid levels. That's only 7% of the requested funding level. That's after 2015 saw the first drop in support in five years (see pages 21-22) in funding for AIDS efforts in low- and middle-income countries. The world spends an estimated $100 billion a year on fighting drugs, but it can't come up with 2.3% of that figure to fight drug-related AIDS harms. Harm Reduction International has proposed a "10x20" shift of 10% of law enforcement funding toward harm reduction services by 2020 to address the gap.

Harm reduction's global funding challenges are further impacted by the global AIDS-fighting budget, which has taken a hit as the rise in the dollar has reduced the spending power of contributions from donor countries that use other currencies. Even worse, many of the countries currently benefiting from UN harm reduction funding have progressed economically to a point at which they are supposed to begin funding their own programs according to the UN development framework. But that may not be a realistic expectation, especially for the sometimes politically fraught programs needed to address disease transmission related to drug use.

3. America's Most Populous State Legalizes Marijuana, and So Do Several More. You know the global prohibitionist consensus is crumbling when the rot sets in at home, and that's what happened in November's US elections. California, Nevada, Maine, and Massachusetts all voted to legalize marijuana, joining Alaska, Colorado, Oregon, and Washington, which had led the way in 2012 and 2014. Now, some 50 million Americans live in pot-legal states, and that's going to mean increasing pressure on the government in Washington to end federal pot prohibition. It's also an example to the rest of the world.

4. Europe's Prohibitionist Consensus Begins Crumbling Around the Edges. No European nation has legalized marijuana, but signs are increasing that somebody is going to do it soon. If 2016 was any indication, the best candidates may be Italy, where a broadly supported legalization bill got a parliamentary hearing this year before surprise election results upset the country's political apple cart; Germany, where "legalization is in the air" as Berlin moves toward allowing cannabis coffee shops and Dusseldorf moves toward total marijuana legalization; and Denmark, where Copenhagen is trying yet again to legalize weed. In both Denmark and Germany, legalization isn't currently favored by the central governments, while in Italy, everything is in limbo after Europe's populist uprising swept the prime minister out of office. Still, the pressure is mounting in Europe.

Amsterdam's famed cannabis coffee houses look set to final get a legal source of supply. (Wikimedia.org)
5. The Dutch Are Finally Going to Do Something About the "Back Door Problem." The Dutch have allowed for the sale of marijuana at "coffee shops" since the 1980s, but never made any provision for a legal pot supply for retailers. Now, after 20 years of blocking any effort to decriminalize marijuana production, Prime Minister Mark Rutte's VVD party has had a change of heart. At a party conference in November, the VVD voted to support "smart regulation" of marijuana and "to redesign the entire domain surrounding soft drugs." The full text of the resolution, supported by 81% of party members, reads: "While the sale of cannabis is tolerated at the front door, stock acquisition is now illegal. The VVD wants to end this strange situation and regulate the policy on soft drugs in a smarter way. It's time to redesign the entire domain surrounding soft drugs. This redevelopment can only take place on a national level. Municipalities should stop experiments with cannabis cultivation as soon as possible." The opposition political parties are already in support of solving the long-lived "back door problem."

6. Canada's Move Toward Marijuana Legalization Continues Apace. report issued in DecemberBolivian President Evo Morales, a former coca grower union leader himself, opened the year campaigning to decriminalize the coca tradeinking an agreement with Ecuador

Mexico's latest drug war marked its 10th anniversary last month. (Wikimedia.org)
8. Mexico Marks a Decade of Brutal Drug Wars. In December, 2006, then-President Felipe Calderon sent the Mexican army into the state of Michoacan in what he said was a bid to get serious about fighting the drug trade. It didn't work, and in fact, led to the worst prohibition-related violence in the country's history, with an estimated 100,000 + killed and tens of thousands more gone missing. Attention to the cartel wars peaked in 2012, which was a presidential election year in both the US and Mexico, and the level of killing declined after that, but has now risen back to those levels. Calderon's replacement, Enrique Pena Nieto, has publicly deemphasized the drug war, but has not substantially shifted the policy. The arrest of Sinaloa Cartel leader Joaquin "El Chapo" Guzman has weakened his cartel, but that has only led to more violence as new competitors vie for supremacy.

There are signs of hope on the policy front though, if early ones, with medical marijuana being implemented, attitudes toward legalization softening, and the government playing a role in forwarding the international debate on drug policy reform.

9. Iran Has Second Thoughts About the Death Penalty for Drugs. The Islamic Republic is perhaps the world's leading drug executioner, with drug offenders accounting for the vast majority of the more than a thousand people it executed in 2015 (2016 numbers aren't in yet), but there are increasing signs the regime could change course. In November, the parliament agreed to expedite deliberations on a measure that would dramatically limit the number of people facing execution for drugs. Now, the proposal will get top priority in the Legal and Social Affairs Committee before heading before the full parliament. The measure would limit the death penalty to "organized drug lords," "armed trafficking," "repeat offenders," and "bulk drug distributors."

10. The Philippines Wages a Bloody War on Drug Users and Sellers. With the election of former Davao City Mayor Rodrigo Duterte as president, the country descended into a veritable blood-bath, as police and "vigilantes" seemingly competed to see who could kill more people faster. Duterte has brushed off criticism from the US, the UN, and human rights groups, and even insulted his critics, although he did have kind words to say about Donald Trump, who had kind words to say about him. As of year's end, the death toll was around 6,000, with the vigilantes claiming a slight lead over the cops.

Permission to Reprint: This content is licensed under a modified Creative Commons Attribution license. Content of a purely educational nature in Drug War Chronicle appear courtesy of DRCNet Foundation, unless otherwise noted.

Add new comment

The content of this field is kept private and will not be shown publicly.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.